KR101380813B1 - 2형 당뇨병 치료용 병용 의약 - Google Patents

2형 당뇨병 치료용 병용 의약 Download PDF

Info

Publication number
KR101380813B1
KR101380813B1 KR1020077025214A KR20077025214A KR101380813B1 KR 101380813 B1 KR101380813 B1 KR 101380813B1 KR 1020077025214 A KR1020077025214 A KR 1020077025214A KR 20077025214 A KR20077025214 A KR 20077025214A KR 101380813 B1 KR101380813 B1 KR 101380813B1
Authority
KR
South Korea
Prior art keywords
mitiglinide
diabetes
type
hba
hydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020077025214A
Other languages
English (en)
Korean (ko)
Other versions
KR20070118163A (ko
Inventor
유지 기요노
요시오 오쿠보
가츠미 혼타니
이마오 미코시바
가즈마 오지마
Original Assignee
깃세이 야쿠힌 고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 깃세이 야쿠힌 고교 가부시키가이샤 filed Critical 깃세이 야쿠힌 고교 가부시키가이샤
Publication of KR20070118163A publication Critical patent/KR20070118163A/ko
Application granted granted Critical
Publication of KR101380813B1 publication Critical patent/KR101380813B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020077025214A 2005-04-20 2006-04-18 2형 당뇨병 치료용 병용 의약 Expired - Fee Related KR101380813B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JPJP-P-2005-00121862 2005-04-20
JP2005121862 2005-04-20
JPJP-P-2005-00166314 2005-06-07
JP2005166314 2005-06-07
PCT/JP2006/308110 WO2006115115A1 (ja) 2005-04-20 2006-04-18 ２型糖尿病治療用の併用医薬

Publications (2)

Publication Number Publication Date
KR20070118163A KR20070118163A (ko) 2007-12-13
KR101380813B1 true KR101380813B1 (ko) 2014-04-04

Family

ID=37214736

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077025214A Expired - Fee Related KR101380813B1 (ko) 2005-04-20 2006-04-18 2형 당뇨병 치료용 병용 의약

Country Status (7)

Country Link
US (1) US7888382B2 (https=)
EP (1) EP1872781A4 (https=)
JP (3) JP4230524B2 (https=)
KR (1) KR101380813B1 (https=)
CN (1) CN101198326B (https=)
CA (1) CA2605302A1 (https=)
WO (1) WO2006115115A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2605302A1 (en) * 2005-04-20 2006-11-02 Kissei Pharmaceutical Co., Ltd. Combined pharmaceutical preparation for treatment of type 2 diabetes
CN105296620B (zh) 2015-10-26 2019-01-15 上海市内分泌代谢病研究所 肠道宏基因组特征作为2型糖尿病阿卡波糖疗效筛选标志
JP7680822B2 (ja) * 2017-08-08 2025-05-21 日本ケミファ株式会社 糖尿病治療剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040490A1 (en) 2000-02-24 2003-02-27 Yasuo Sugiyama Drugs containing combined active ingredients
WO2004002473A1 (ja) 2002-06-28 2004-01-08 Kissei Pharmaceutical Co., Ltd. 血糖コントロール用医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4917712B2 (ja) 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
US6830759B2 (en) * 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
US20050020654A1 (en) * 2003-03-15 2005-01-27 Pershadsingh Harrihar A. Novel PPAR agonists, pharmaceutical compositions and uses thereof
EP1679965A4 (en) * 2003-08-01 2009-05-27 Janssen Pharmaceutica Nv SUBSTITUTED ANELLIERED HETEROCYCLIC C-GLYCOSIDES
US20050197376A1 (en) * 2004-03-02 2005-09-08 Fujisawa Pharmaceutical Co. Ltd. Concomitant drugs
CA2605302A1 (en) * 2005-04-20 2006-11-02 Kissei Pharmaceutical Co., Ltd. Combined pharmaceutical preparation for treatment of type 2 diabetes
CA2622558A1 (en) 2005-09-14 2007-03-22 Elixir Pharmaceuticals, Inc. Combination therapy for controlled carbohydrate digestion

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040490A1 (en) 2000-02-24 2003-02-27 Yasuo Sugiyama Drugs containing combined active ingredients
WO2004002473A1 (ja) 2002-06-28 2004-01-08 Kissei Pharmaceutical Co., Ltd. 血糖コントロール用医薬組成物

Also Published As

Publication number Publication date
CN101198326A (zh) 2008-06-11
EP1872781A4 (en) 2009-04-01
CN101198326B (zh) 2011-10-12
JP2008189679A (ja) 2008-08-21
US20090030063A1 (en) 2009-01-29
WO2006115115A1 (ja) 2006-11-02
CA2605302A1 (en) 2006-11-02
EP1872781A1 (en) 2008-01-02
US7888382B2 (en) 2011-02-15
JP5117230B2 (ja) 2013-01-16
JP2012092140A (ja) 2012-05-17
JP4230524B2 (ja) 2009-02-25
JPWO2006115115A1 (ja) 2008-12-18
KR20070118163A (ko) 2007-12-13

Similar Documents

Publication Publication Date Title
JP6676108B2 (ja) ２型糖尿病の処置のためのリキシセナチド及びメトホルミン
JP2004155791A (ja) 新規ｎｉｄｄｍ療法
US12042472B2 (en) Sublingual epinephrine tablets
JP2008509145A (ja) 抗糖尿病性経口インスリン−ビグアニドの組み合わせ
CN103402506A (zh) 用于治疗糖尿病的组合
TW200838503A (en) Pharmaceutical composition
KR100709528B1 (ko) 혈당콘트롤용 의약조성물
JP5117230B2 (ja) ２型糖尿病治療用の併用医薬
US20220184006A1 (en) Combination therapy
Bell Focusing on cardiovascular disease in type 2 diabetes mellitus: an introduction to bromocriptine QR
KR100709531B1 (ko) 당뇨병성 합병증의 예방 또는 진전저지용 의약조성물
UA128573C2 (uk) Способи лікування підвищення маси тіла, індукованого антипсихотичними засобами, за допомогою мірикориланту
CA3158745C (en) Methods of treating antipsychotic-induced weight gain with miricorilant
CN114401724B (zh) 一种降糖药物组合物
US20040176457A1 (en) Novel NIDDM regimen
HK40076638A (en) Methods of treating antipsychotic-induced weight gain with miricorilant
TW202529797A (zh) Ｇｌｐ－１類似物治療代謝疾病的方法及醫藥用途
MX2015003810A (es) Metadoxina para usarse en el tratamiento de enfermedades hepaticas y formulaciones de liberacion prolongada de metadoxina.
WO2012133693A1 (ja) 糖尿病治療用の組合せ医薬
CN101869562A (zh) 左旋氨氯地平复方药物制剂
JP2007091641A (ja) ２型糖尿病治療用の併用医薬
CN101773500A (zh) 抗高血压的药物组合物
HK1194307B (en) Lixisenatide and metformin for treatment of diabetes type 2
HK1137345A (en) Combination treatment for diabetes mellitus

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20170118

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20180112

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20181221

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20200121

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20220328

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20220328